Urinary Catheter Market
By Product (Indwelling Catheters [Transurethral Catheters, Suprapubic Catheters], External Catheters [Vaccum Assisted Catheters, Non-Vaccum Assisted Catheters], Intermittent Catheters),
By Coating (Coated Catheters and Uncoated Catheters),
By Usage (Male Catheters and Female Catheters),
By Application (Urinary Incontinence, Prostate Enlargement, and Surgery),
By Material (Latex, PVC, and Silicone),
By End Use (Hospitals and Clinics, Care Facilities and Home Care),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):
Urinary Catheter Market - Global Analysis and Forecast 2023-2033
The global Urinary Catheters market is to be worth more than USD 6 billion by 2033.
A urinary catheter is a simple, flexible tube connecting the bladder to a urine drainage bag. The simple medical device is used for middle-aged and older patients who can't urinate independently or experience impaired control over urination. The rise in the geriatric population is the prime factor boosting the market growth for urinary catheters. This is also interlinked with the number of surgeries carried out per year. Surgical procedures require a short-term recovery period, during which usage of short-term urinary catheters becomes necessary. As per the current analysis, both rise in the geriatric population as well as chronic disorders are going to trigger the growth of the urinary Catheter market. One of the most influential chronic conditions that lead to urinary incontinence is prostate enlargement in men and postmenopausal stress in women. Both of these conditions are age-related and thus inevitable. Further analysis reveals the boosting role of innovation in bacterial-resistant properties of catheter material to prevent urinary tract infections. These innovations are enhancing patient compliance rates by reducing the discomfort of infections.
The companies operating within the Urinary catheter industry are undergoing mergers, collaboration, acquisition, long-term contracts, and service agreements to increase their global footprint. For instance, Coloplast opened its operational hub in Peterborough, which would help the company expand its footprint in the England region. Furthermore, notable investment towards research and development to launch new and innovative products that support UTI resistance at multiple levels is also practiced by industry stakeholders.
According to the CXOs and primary research conducted, COVID-19 negatively impacted the Urinary catheter market while the patient count of prostate cancer and other chronic diseases was still rapidly growing during the widespread infection. It is so because the supply chain dynamics of raw materials for catheter manufacturing were disrupted. The raw materials production, such as polymers, Latex, silicon, or PVC, could not meet the demand for manufacturing of urinary catheters. However, the piled-up cases of prostate enlargement and other chronic disorders did boost the market growth post-pandemic.
The Urinary catheter market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In line with the analyzed region, the Asia-Pacific region will witness the highest market share, followed by North America, Europe, Latin America, and Middle East & Africa. The rise in the geriatric population, emerging economies coupled with flexibility in regulatory affairs, and major industry players within the region are primary factors supporting market potential within the Asia-Pacific region. The major companies operating within the market are Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, Coloplast Ltd., Cook Medical, ConvaTech Inc., Cardinal Health, Edwards Lifesciences Corporation, Johnson & Johnson, and Stryker Corporation.
